sexual desire
Showing 1 - 25 of 3,347
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Female Sexual Interest/Arousal Disorder Trial in Castelldefels (Libicare, active control)
Not yet recruiting
- Female Sexual Interest/Arousal Disorder
- Libicare
- active control
-
Castelldefels, Barcelona, SpainProcare Health Iberia
Dec 1, 2022
Hypoactive Sexual Desire Disorder Trial in Seoul (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 15, 2022
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
Recruiting
- Sexual Desire
-
Basel, SwitzerlandUniversity Hospital Basel, Endocrinology, Diabetes and Metabolis
Nov 28, 2022
Sexuality, Sexual Dysfunction, Sexual Desire Disorder Trial in Los Angeles (Vibrator)
Recruiting
- Sexuality
- +9 more
- Vibrator
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 18, 2022
Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
London, United KingdomImperial College Healthcare NHS Trust
Mar 9, 2022
Sexual Desire Disorder Trial in Santa Monica (DLM - Test product)
Completed
- Sexual Desire Disorder
- DLM - Test product
-
Santa Monica, CaliforniaCitruslabs
Jan 5, 2022
Hypoactive Sexual Desire Disorder Trial in San Diego (sex therapy, flibanserin)
Terminated
- Hypoactive Sexual Desire Disorder
- sex therapy
- flibanserin
-
San Diego, CaliforniaSan Diego Sexual Medicine
Jun 8, 2022
Low Female Sexual Desire Trial in Vancouver (Mindfulness-based treatment, Sex therapy, education, and support treatment)
Completed
- Low Female Sexual Desire
- Mindfulness-based treatment
- Sex therapy, education, and support treatment
-
Vancouver, British Columbia, CanadaDepartment of Gynaecology
Apr 26, 2021
Desire; Sexual, Aversion, Paraphilia Trial (transcutaneous (superficial) afferent electrical nerve stimulation specific for
Not yet recruiting
- Desire; Sexual, Aversion
- Paraphilia
- transcutaneous (superficial) afferent electrical nerve stimulation specific for vagus nerve
- (no location specified)
Jul 28, 2022
Hypoactive Sexual Desire Disorder Trial in Chicago (Flibanserin, Placebo)
Unknown status
- Hypoactive Sexual Desire Disorder
- Flibanserin
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Jan 15, 2021
Hypoactive Sexual Desire Disorder Trial in Bochum (Cognitive-behavioral treatment, Mindfulness-based treatment)
Unknown status
- Hypoactive Sexual Desire Disorder
- Cognitive-behavioral treatment
- Mindfulness-based treatment
-
Bochum, NRW, GermanyRuhr University Bochum
Oct 6, 2020
Real Life to Describe Libicare® Effectiveness in Female Sexual
Completed
- Female Sexual Dysfunction
- Patients' data (baseline characteristics, clinical and outcomes) from routine care visits
-
Madrid, SpainInstituto Palacios de Salud y Medicina de la Mujer
Feb 8, 2021
Sexual Behavior, Sexual Orientation Conflict Disorder, Sexual Arousal Disorder Trial in Nasiriyah (H - Test)
Enrolling by invitation
- Sexual Behavior
- +4 more
- H - Test
-
Nasiriyah, Thi Qar, IraqNo name
Dec 11, 2020
Chemsex, Perceived Risks and Coping Strategies.
Completed
- Sexual; Sexual Desire
- +2 more
- Intervention
-
Montpellier, FranceUhmontpellier
Nov 16, 2020
Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder Trial in Nasiriyah (JT Device)
Enrolling by invitation
- Sexual Dysfunction
- +9 more
- JT Device
-
Nasiriyah, Thi Qar, IraqHashim Talib Talib Hashim
Dec 5, 2020
Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Withdrawn
- Hypoactive Sexual Desire Disorder (HSDD)
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +9 more
Jul 29, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Completed
- Hypoactive Sexual Desire Disorder
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +68 more
Apr 7, 2021
Menopause, Metabolic Syndrome, Hypoactive Sexual Desire Disorder Trial in São Paulo (Female sexual function index questionnaire,
Completed
- Menopause
- +4 more
- Female sexual function index questionnaire
- +2 more
-
São Paulo, BrazilRua Maria José Pomar, 322 Apartamento 172 C
Dec 30, 2019
Hypoactive Sexual Desire Disorder Trial in Canada, United States (testosterone gel, gel)
Completed
- Hypoactive Sexual Desire Disorder
- testosterone gel
- placebo gel
-
Birmingham, Alabama
- +148 more
Oct 27, 2021
Hypoactive Sexual Desire Disorder Trial in London (Intrinsa Transdermal testosterone patch)
Completed
- Hypoactive Sexual Desire Disorder
- Intrinsa Transdermal testosterone patch
-
London, United Kingdom
- +2 more
Dec 13, 2019
Hypoactive Sexual Desire Disorder Trial in Waukesha (Placebo vulvar cream, Estradiol vulvar cream)
Completed
- Hypoactive Sexual Desire Disorder
- Placebo vulvar cream
- Estradiol vulvar cream
-
Waukesha, WisconsinWaukesa Memorial Hospital
Mar 11, 2020
Hypoactive Sexual Desire Disorder, Female Sexual Dysfunction, Sexual Desire Disorder Trial in Russian Federation (BP101,
Completed
- Hypoactive Sexual Desire Disorder
- +2 more
- BP101
- Placebo
-
Barnaul, Russian Federation
- +19 more
Feb 10, 2020
Clitoral Arteries' Hemodynamic Parameters.
Completed
- Hypoactive Sexual Desire Disorder
- +5 more
- Testosterone gel
- +3 more
-
Florence, ItalyAndrology, Women's Endocrinology and Gender Incongruence Unit, U
Apr 3, 2020